Caleres Inc files an 8-K: Results of Operations and Financial Condition
Caleres filed an 8-K with the SEC covering its results of operations and financial condition, along with an officer departure or appointment and compensatory arrangements. Investors can review the filing for the reported figures and the changes in officer roles.
From the filing
Item 2.02: Results of Operations and Financial Condition; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 9.01: Financial Statements and Exhibits
Items listed in the filing. The full text is at SEC EDGAR.
Who is reporting it
- GlobeNewswirefirst at Nov 16, 2026, 4:00 AM ESTRead at GlobeNewswire (opens in a new tab)
- SEC EDGARfirst at Nov 16, 2026, 6:01 AM ESTRead at SEC EDGAR (opens in a new tab)
- PR Newswirefirst at Nov 16, 2026, 6:30 AM ESTRead at PR Newswire (opens in a new tab)
- Seeking Alphafirst at Nov 16, 2026, 7:10 AM ESTRead at Seeking Alpha (opens in a new tab)
Story so far
Reported by 6 sources
On November 16, 2026, a run of companies released third quarter 2026 results, including Niu Technologies, iQIYI, XPENG, KE Holdings, H World Group, 22nd Century Group, TOYO, and GT Biopharma.
- Nov 16, 2026, 4:00 AM EST · GlobeNewswireConfirmedNiu Technologies Announces Unaudited Third Quarter 2026 Financial Results
- Nov 16, 2026, 4:00 AM EST · GlobeNewswireConfirmediQIYI Announces Third Quarter 2026 Financial Results
- Nov 16, 2026, 4:40 AM EST · GlobeNewswireConfirmedXPENG Reports Third Quarter 2026 Unaudited Financial Results
- Nov 16, 2026, 5:00 AM EST · GlobeNewswireConfirmedKE Holdings Inc. Announces Third Quarter 2026 Unaudited Financial Results
- Nov 16, 2026, 5:15 AM EST · GlobeNewswireConfirmedH World Group Limited Reports Third Quarter of 2026 Unaudited Financial Results
- Nov 16, 2026, 6:00 AM EST · GlobeNewswireConfirmed22nd Century Group Reports Third Quarter 2026 Financial Results
- Nov 16, 2026, 6:01 AM EST · SEC EDGARConfirmedSilexion Therapeutics Corp files an 8-K: Results of Operations and Financial Condition
Comments
Log in or create a free account to comment.
No comments yet.
The headline links to the original source; the summary is written by The Market Standard. Nothing here is financial advice.